B lymphocytes subpopulations are associated with cardiac remodeling in elderly patients with advanced chronic kidney disease

• Published in: Experimental gerontology Vol. 163; p. 111805
• Main Authors: Lin, Jieshan, Tang, Bin, He, Ganyuan, Feng, Zhanwu, Hao, Wenke, Hu, Wenxue
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 15.06.2022
• Subjects: Aged; B cells; B-Lymphocyte Subsets; Biomarkers; Cardiac remodeling; Chronic kidney disease; Echocardiography; Elderly; Female; Humans; Male; Natriuretic Peptide, Brain; Renal Insufficiency, Chronic - complications; Retrospective Studies; Ventricular Remodeling; Chronic kidney disease; B cells; Cardiac remodeling; Elderly
• ISSN: 0531-5565; 1873-6815; 1873-6815
• DOI: 10.1016/j.exger.2022.111805

Chronic Kidney Disease (CKD) is independently associated with increased cardiovascular disease (CVD) risk. The aim of this study was to investigate the potential roles of B lymphocyte populations with cardiac remodeling in elderly patients with advanced CKD. We designed a retrospective study in a cohort of 167 patients (84 advanced CKD patients with stage 4–5 and 83 non-CKD controls). B cell subsets: CD19(+)CD5(+) and CD19(+)CD5(−) B cells were identified by flow cytometry. Correlation of B cells subsets with cardiac remodeling and clinical data in elderly CKD patients were analyzed. In this study, we found that the prevalence of hypertension was more common in CKD patients than in the control subjects (P < 0.05). Spearman's analysis showed that CD19(+)CD5(+) B cells were negatively correlated with high sensitivity C-reactive protein (hsCRP), β2-microglobulin (β2-MG), serum creatinine (SCr), pro-brain natriuretic peptide (pro-BNP), high-sensitivity troponin T (TNT-hs), left ventricle end-diastolic dimension (LVDD), left ventricle end-systolic dimension (LVSD) and left ventricular mass (LVM), and CD19(+)CD5(−) B cells were negatively correlated with β2-MG, SCr, pro-BNP and TNT-hs (P < 0.05). In contrary, left ventricular ejection fractions (LVEF) was positively correlated with CD19(+)CD5(+) and CD19(+)CD5(−) B cells (P < 0.05). In addition, patients with higher levels of CD19(+)CD5(+) B cells exhibited lower level of pro-BNP, TNT-hs, interventricular septum (IVS), LVSD and LVM (P < 0.05). Higher levels of CD19(+)CD5(−) B cells also presented lower levels of pro-BNP, TNT-hs and LVSD, but higher levels of LVEF (P < 0.05). Cox regression analysis showed that patients with higher levels of LVSD, lower CD19(+)CD5(+)and CD19(+)CD5(−) B cells counts have a higher risk of all-cause mortality (P < 0.05). Our results showed that CD19(+)CD5(+) and CD19(+)CD5(−) B lymphocytes were negatively correlated with ventricular hypertrophy-related echocardiographic parameters in advanced CKD patients, which indicated that B lymphocytes might be involved in pathogenesis and improve cardiac remodeling in CKD patients. •Patients with higher levels of LVSD, lower CD19(+)CD5(+)and CD19(+)CD5(–) B cells counts have a higher risk of all-cause mortality.•CD19(+)CD5(+) and CD19(+)CD5(–) B lymphocytes were negatively correlated with ventricular hypertrophy-related echocardiographic parameters in advanced CKD patients.•B lymphocytes might be involved in pathogenesis and improve cardiac remodeling in CKD patients.